AwesomeCapital
Thursday, October 31, 2019
Shingrix and Trelegy shield Glaxo from Advair fallout
›
GlaxoSmithKline is expecting flat earnings this year, having earlier forecast a decline, as rising sales of new drugs have helped offset th...
Astellas cuts $795m deal with Pandion for type 1 diabetes drugs
›
Astellas Pharma is boosting its early-stage pipeline with a $45 million upfront deal to license bispecific antibodies from US biotech Pandi...
Eloxx Pharma up 19% on positive ELX-02 data
›
Thinly traded micro cap Eloxx Pharmaceuticals ( ELOX +19.2% ) is up on almost 50% higher volume, albeit on turnover of only 127K shares, ...
How measles infections can wipe away immunity to other diseases
›
Measles wipes out some of the immunity to other diseases that children acquire through vaccinations and infections, leaving them more vulne...
CHS stock plunges after announcing debt swap plan
›
Shares of Franklin, Tenn.-based Community Health Systems closed Oct. 30 at $3.82, down 16.6 percent from the day prior. The decline came ...
Apple reports modest revenue growth, led by 54% surge in wearables
›
Apple reported total revenues of $64 billion for the fiscal fourth quarter ended Sept. 28, a year-over-year increase of 2 percent, in an e...
ICU Medical recalls 2 IV fluids
›
ICU Medical is recalling two intravenous fluids that were sent to hospitals nationwide. The recall affects one lot of ICU Medical’s lac...
‹
›
Home
View web version